IP Library Granted Patent US 8,252,344
Granted Patent B2
US 8,252,344 · App. 10/939,869 · Granted Aug 28, 2012

Partially hydrated hemostatic agent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,252,344
App. No.
10/939,869
Granted
Aug 28, 2012
Kind
B2
Abstract

A composition for promoting the formation of clots in blood comprises a zeolite and a binder. The zeolite is adjusted to have a specific moisture content. Processes by which the moisture content is adjusted include drying, re-hydrating, and combinations of drying and re-hydrating. A method of forming the composition comprises the steps of providing a zeolite and adjusting the moisture content such that upon application of the composition to a wound, a heat of hydration is reduced and heat transferred to the wound is reduced. A method of clotting blood flowing from a wound comprises the steps of applying the zeolite to the wound and maintaining the zeolite in contact with the wound for a predetermined amount of time, the zeolite having an adjusted moisture content and being capable of producing a controllable exothermic effect on the wound.

Claims (21)

1. A composition for promoting clotting of blood, said composition comprising:

a binder comprising a clay; and

a partially hydrated zeolite disposed in said binder;

wherein the composition is in a solid form;

wherein said zeolite has a moisture content of from 10% to 15% water by weight;

wherein said moisture content of the partially hydrated zeolite is configured to provide a substantially reduced heat of hydration upon application of said partially hydrated zeolite to a wound, as compared to a completely dried amount of said zeolite; and

wherein the partially hydrated zeolite with said moisture content is configured to accelerate clotting of blood.

2. The composition of claim 1 , wherein said zeolite comprises aluminosilicate A-type crystals.

3. The composition of claim 1 , wherein said zeolite is ion-exchanged to include a cation selected from the group consisting of calcium, sodium, potassium, silver, magnesium, and combinations of any of the foregoing cations.

4. The composition of claim 1 , wherein said zeolite is nanoporous.

5. The composition of claim 1 , wherein said composition is of an irregularly shaped granular form having a size distribution determined by sieving ground material with 40 mesh and 16 mesh cut-off screens.

6. A method of forming a blood-clotting composition, said method comprising the steps of:

providing a zeolite in a solid form; adjusting a moisture content of said zeolite to have a specific moisture content from 10% to 15% water by weight;

such that upon application of said composition to a wound, a heat of hydration is reduced and heat transferred to said wound is reduced as compared to a completely dried amount of said zeolite.

7. The method of claim 6 , wherein said adjusting said moisture content of said zeolite comprises incompletely drying said zeolite.

8. The method of claim 6 , wherein said adjusting said moisture content of said zeolite comprises incompletely re-hydrating said zeolite.

9. A method of clotting blood flowing from a wound, said method comprising the steps of:

applying a zeolite to said wound, said zeolite having an adjusted moisture content that is at least 10% water by weight and less than 15% water by weight, and said zeolite is capable of reducing the amount of heat generated by contact between the zeolite and the flowing blood as compared to a completely dried amount of said zeolite;

wherein the zeolite is capable of accelerating clotting of blood; and

wherein the zeolite is in a solid form;

maintaining said zeolite in contact with said wound for an amount of time sufficient to substantially reduce the flow of blood.

Assignments (21)
SECURITY INTEREST Recorded Mar 1, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066723/0376 →
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066621/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066616/0701 →
CHANGE OF NAME Recorded Feb 16, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066621/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
SECURITY INTEREST Recorded Mar 2, 2021
From: Z-MEDICA, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055455/0099 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2021
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: Z-MEDICA, LLC
Reel/Frame 054832/0770 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INADVERTENT OMISSION OF APPLICATION NO. 14/185873 FROM THE COVER SHEET PREVIOUSLY RECORDED AT REEL: 044151 FRAME: 0282. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 22, 2020
From: MADISON CAPITAL FUNDING LLC
To: Z-MEDICA, LLC
Reel/Frame 054882/0904 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 035308/0704 Recorded Oct 9, 2017
From: MADISON CAPITAL FUNDING LLC
To: Z-MEDICA, LLC
Reel/Frame 044151/0282 →
SECURITY INTEREST Recorded Sep 29, 2017
From: Z-MEDICA, LLC
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 043738/0690 →
RELEASE AND REASSIGNMENT Recorded Apr 9, 2015
From: ABACUS FINANCE GROUP, LLC
To: Z-MEDICA, LLC
Reel/Frame 035389/0800 →
SECURITY INTEREST Recorded Apr 1, 2015
From: Z-MEDICA, LLC
To: MADISON CAPITAL FUNDING LLC, AS AGENT
Reel/Frame 035308/0704 →
MERGER Recorded Apr 1, 2015
From: Z-MEDICA CORPORATION
To: Z-MEDICA, LLC
Reel/Frame 035353/0423 →
SECURITY AGREEMENT Recorded Sep 6, 2012
From: Z-MEDICA, LLC
To: ABACUS FINANCE GROUP, LLC
Reel/Frame 028917/0898 →
MERGER Recorded Sep 4, 2012
From: Z-MEDICA CORPORATION
To: Z-MEDICA, LLC
Reel/Frame 028896/0108 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUS RECORDATION OF THE ASSIGNMENT AGAINST APPL. NOS. 11/054,918; 60/671,192; 11/082,716; 11/082,320; 11/174,255 PREVIOUSLY RECORDED ON REEL 016585 FRAME 0177. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT SHOULD NOT HAVE BEEN RECORDED AGAINST THESE APPLICATIONS. Recorded Sep 29, 2005
From: Z-MEDICA, LLC
To: Z-MEDICA CORPORATION
Reel/Frame 016612/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2005
From: Z-MEDICA, LLC
To: Z-MEDICA CORPORATION
Reel/Frame 016585/0177 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2004
From: HURSEY, FRANCIS X.
To: Z-MEDICA
Reel/Frame 015357/0045 →